$CWNM Non-medical applications, though not explicitly addressed here, include the use of the technology in the areas of water treatment, odor control, and experimental research. The CDDT patent estate is currently owned by Farrington Pharmaceuticals. Crown Marketing Pharmaceuticals acquired the license of the CDDT technology from Farrington.